13F-HR filed by Syncona Portfolio Ltd
Syncona Portfolio Ltd filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-07-27, with 4 holding rows worth $66,342,387.
- Accession
- 0000950123-23-006361
- Filer
- CIK 1725042
- Filed
- 2023-07-27
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A combination report, 4 entries on the cover page, a total value of $66,342,387 stated on the cover page (in dollars after the unit check, H1), rows summing to $66,342,387 with VALUE read as dollars as filed, 13F file number 028-21839. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerSyncona Holdings Limited
- reports for this filerSyncona Limited
- reports for this filerSyncona Investment Management Limited
- included managerSyncona Holdings Limited
- included managerSyncona Limited
- included managerSyncona Investment Management Limited
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 21,346,829 | $50,805,453 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 11,086,909 | $10,479,346 | dollars as filed | |
| FREELINE THERAPEUTICS HLDGS | 35655L107 | SPONSORED ADS | 1,466,508 | $3,783,591 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,377,294 | $1,273,997 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-006361 | this filing | 2023-07-27 | acceptance time not in the bulk data set |